Sharon Bio Medicine

What Sharon Bio Medicine does

Sharon Bio-Medicine Limited is an Indian pharmaceutical company, founded in 1989 and headquartered in Navi Mumbai, that operates as a B2B contract manufacturer and service provider to global pharmaceutical companies. It is a publicly listed entity on the Bombay Stock Exchange (bom:532908) and a subsidiary of Univentis Medicare Ltd. The company's operations span three integrated facilities: a cGMP-compliant API manufacturing plant at Taloja (over 40,000 liters of reaction capacity and 2,000+ kg/day packaging) producing intermediates and active pharmaceutical ingredients across therapeutic categories including anti-fungal, cardiovascular, anti-depressant, anti-Alzheimer, muscle relaxant, anti-diabetic, GI pro-kinetic and anti-psychotic drugs; an oral solid dosage formulation plant at Dehradun operational since 2007 with annual capacity of 3,000 million tablets and 400 million capsules; and the SA-FORD division, an OECD GLP-certified and AAALAC-accredited preclinical toxicology CRO established in 2008.

The company monetizes through three revenue streams: contract manufacturing of finished dosage forms (tablets and capsules) on a transaction/contract basis, API manufacturing and sale on a transaction basis, and preclinical toxicology studies as professional services. Pricing is quote-based, negotiated per customer specification with no public disclosure. Distribution is direct B2B sales targeting global pharmaceutical enterprises in markets including the US, EU, UK, Canada, Australia, Korea, Taiwan, Russia, Ukraine and Colombia, supported by a broad set of international regulatory approvals (US FDA, EU GMP, WHO GMP, UK MHRA, KFDA, Health Canada, TGA Australia, EDQM).

The company underwent a Corporate Insolvency Resolution Process from April 2017 through June 2022, after which it continued operating and has since reset its leadership (CEO Kaushik Banerjee appointed) and resumed trade-show participation (e.g., CPHI 2025). Headcount is reported in the 251-500 band and revenue is not publicly disclosed. Beyond core manufacturing, the company offers regulatory affairs services (DMF and Dossier compilation), process development and scale-up, and full-shelf-life stability monitoring to support ANDA and CTD dossier filings for global pharmaceutical customers.

Name

Sharon Bio Medicine

Legal name

Sharon Bio-Medicine Limited

Website

https://sharonbio.com

Company type

Public

Founded year

1989

Operating status

Operating

Headcount range

251–500 employees

Short description

Sharon Bio-Medicine is an Indian BSE-listed pharmaceutical contract manufacturer serving global pharma companies with cGMP API manufacturing (Taloja), oral solid dosage formulation (Dehradun), and OECD GLP-certified preclinical toxicology services (SA-FORD). It is a subsidiary of Univentis Medicare Ltd.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Medicinal and Botanical Manufacturing (325411), Scientific Research and Development Services (5417)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)

akta.pro secondary industries

Small-Molecule Analytical Development & Method Validation (CMC) (HLAGAHAF), Solid-State Chemistry & Preformulation (Polymorph/Crystallization) (HLAGAHAI), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Active pharmaceutical ingredients
• Pharmaceutical contract manufacturing
• Finished dosage formulations
• Preclinical toxicology services
• Pharmaceutical intermediates

Headquarters

HQ city

Vashi

HQ country

India

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Contract Manufacturing - Formulation: Manufacturing of finished dosage forms (tablets and capsules) for global pharmaceutical companies under contract manufacturing arrangements. Facility operates with annual capacity of 3000 million tablets and 400 million capsules.
2. API (Active Pharmaceutical Ingredients) Manufacturing: Manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients to pharmaceutical companies globally
3. Preclinical Toxicology Services: SA-FORD division provides toxicology services including chemistry, mutagenicity and toxicological studies on rodents for pharmaceutical and chemical companies

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Sharon Bio-Medicine Limited is a B2B pharmaceutical contract manufacturer that produces Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and finished solid oral dosage forms (tablets and hard gelatine capsules) for global pharmaceutical companies. Through its SA-FORD division, the company also provides OECD GLP certified preclinical toxicology services (chemistry, mutagenicity, and toxicological studies on rodents) for pharmaceutical and chemical industry clients.

Product overview

Sharon Bio-Medicine Limited is an Indian pharmaceutical company offering an integrated portfolio of products and services. The core products include Active Pharmaceutical Ingredients (APIs) manufactured at the Taloja cGMP-compliant API facility, and Finished Dosage Forms (tablets and capsules) produced at the Dehradun formulation facility. Supporting services include the SA-FORD division's OECD GLP certified toxicology services, chemical process development and scale-up, regulatory affairs support for DMF and dossier preparation, and stability monitoring. The company operates an integrated business model combining API manufacturing with finished product capabilities, serving global pharmaceutical companies with contract manufacturing services.

Differentiator

Problem solved

Functional benefit

Brands

• SA-FORD: A division of Sharon Bio-Medicine Ltd. offering OECD GLP certified toxicology services related to animals. Stands for 'Sanctuary for Research & Development'.

Products and services

• Active Pharmaceutical Ingredients (APIs) Active Pharmaceutical Ingredients manufactured at the cGMP-compliant Taloja facility, including anti-fungal, cardiovascular, anti-depressant, anti-Alzheimer, muscle relaxant, anti-diabetic, GI pro-kinetic, and anti-psychotic drugs. Sold to pharmaceutical companies globally.
• Pharmaceutical Intermediates Pharmaceutical intermediates manufactured alongside APIs at the cGMP-compliant Taloja facility for global pharmaceutical customers.
• Finished Dosage Forms (Tablets and Capsules)

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered minor and core.

• Lions Club - AiroliminorOthers · 24 March 2022CSR partnership for healthcare. Cataract surgeries performed at Saidrishti Hospital, Sanpada in association with Lions Club Airoli.
• ARPHEN NGOminorOthers · 1 January 2022CSR partnership for education initiatives. Sharon Bio-Medicine distributed Education kits and Benches to students of Zilla Parishad Primary School at Pale Khurd and Devicha Pada, Raigad, Navi Mumbai.
• The Wishing FactoryminorOthers · 1 January 2022CSR partnership for Thalassemia warriors. Sharon adopted around 35 young lives to support Thalassemia patients through The Wishing Factory NGO dedicated to improving lives of underprivileged Thalassemia Warriors in India.
• CFTI (Center for Transforming India)minorOthers · 1 January 2021CSR partnership for rural development. 100 cycles distributed to beneficiaries in Uran and Murud, Maharashtra district in collaboration with CFTI NGO.
• Balaji Sewa SansthanminorOthers · 1 January 2021CSR partnership for women empowerment and healthcare. Two projects: 'Udaan' for vocational training of women and reproductive health awareness for adolescent girls.
• Univentis Medicare Ltd.coreOthersParent/subsidiary relationship. Sharon Bio-Medicine Ltd. is a subsidiary of Univentis Medicare Ltd.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sharon Bio Medicine